Oura seeks $2.2B IPO while partnering with Dexcom and Resmed
What happened
Oura announced partnerships with Dexcom and Resmed to integrate health features into their respective products. The company also disclosed a plan to seek up to $2.2 billion in an initial public offering, estimating shares will be valued between $40 and $44 each.
From yahoo.com
Why it matters
The partnerships allow Oura to expand its health feature offerings by integrating with established medical technology companies. Oura is operating in a market where the distinction between wellness features and regulated medical devices is a key challenge, particularly regarding FDA oversight.
From yahoo.com
Who's involved
- OuraWearables firm seeking IPO and integrating health features
- DexcomCompany developing continuous glucose monitoring systems, partnering with Oura
- ResmedManufacturer of respiratory condition products, partnering with Oura
- Goldman SachsLead underwriter for Oura's Initial Public Offering
- RobinhoodUnderwriter for Oura's upcoming Initial Public Offering
Keep exploring
The entities involved
-
Oura
island in Maldives
Nothing else this week.
-
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
Nothing else this week.
-
Resmed
manufacturer of CPAP masks, machines and products that diagnose, treat or help manage respiratory conditions
Nothing else this week.